[email protected]/(408) 457-3700

About Neurolink

Neurolink is an early stage company developing a novel therapy for the treatment of epilepsy.

Nearly three million Americans suffer from epilepsy, a neurological condition characterized by seizures. One of the most common neurological diseases, epilepsy affects approximately 1% of the population - 1 in 26 people will have epilepsy in their lifetime. While current therapies exist to control symptoms, for many patients, there is no ideal treatment due to limited efficacy and undesirable side effects.

You need to register as an accredited investor before we can show you the details of any investment opportunities.

VentureHealth is currently invite only.

Request An Invite!

Startup's Info

Location:
San Antonio
Markets:
Medical Devices
Therapeutic Areas:
CNS / Neurology, Endocrinology

Followers